German innovation for HIV/AIDS diagnostics used 2.5 million times in
17 December 2008
German biotech company Partec is expanding its global leadership in
specialized HIV monitoring and AIDS patient follow-up diagnostics for
developing and emerging countries. During 2008, 2.5 million patient
tests have been performed with its portable, robust and affordable 'CyFlow'
system, already supporting more than 1 million people living with
The Partec innovation has reduced the average cost of
€160 per year per patient by a factor 20 to
The CyFlow instruments are being successfully used in nearly all
Sub-Saharan African countries. Furthermore, the technique is being
applied in Asia, Latin America, Europe and the US. In December 2008, the
thousandth CyFlow device will be placed since introduction at the XVI
International AIDS Conference in Barcelona in July 2002.
By precisely measuring the CD4 T-lymphocyte concentration from blood
samples, the CyFlow delivers accurate information about the immune
status level of HIV/AIDS patients. This test is necessarily required as
a basis for antiretroviral therapy targeting to stabilize the immune
status which is essential for survival. Approximately, 33 million people
worldwide are living with HIV/AIDS. More than 95% of them reside in
developing countries, especially in Africa and Asia.
HIV/AIDS project award
On World Aids Day at 1st December, Partec announced a global award
competition for NGO projects active in the fight against HIV/AIDS. The
award winner will be supported one year free of cost with the required
diagnostics from Partec.
Until 31st March 2009, applicants may submit a detailed project
description including an explanatory statement why specifically their
project should be chosen.
Further information is available online at
Applications should be directed by email to email@example.com
Technologically, the "CyFlow" is based on the invention of
fluorescence-based "flow cytometry" by Professor Wolfgang Gohde from
German University of Munster. The worldwide first patent application in
flow cytometry was filed almost exactly 40 years ago in December 1968.
Since then, the key technology of Gohde has become a standard method for
automated blood cell and cancer cell analysis in hospitals worldwide.
Bookmark this page